Advanced Urothelial Cancer: Clinical Trials

2 trials for Advanced Urothelial Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Completed 1

Follow Advanced Urothelial Cancer: new trials by email Literature Review of Advanced Urothelial Cancer trials Research Report on Advanced Urothelial Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
Biological samples collection, questionnaires to collect patient reported outcomes - Advanced Breast Cancer, Advanced Gastric Cancer
Phase 2RecruitingUNICANCER4002025-11-142025-12-02
A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.
Carboplatin, Fractionated Cisplatin, Gemcitabine - Advanced Urothelial Cancer, Metastatic Urothelial Cancer
Phase 2 / Phase 3CompletedInstitut Claudius Regaud462015-01-212019-08-09

Interventions

Carboplatin (1)  ·  Gemcitabine (1)

Sponsors

Institut Claudius Regaud (1)  ·  UNICANCER (1)

Countries

France (2)

Top investigators

Barbara Pistilli, MD, PhD (1)